A citation-based method for searching scientific literature

Christopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, Glenn T Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B Stern, Richard Dodel, Bruno Dubois, Robert Holloway, Joseph Jankovic, Jaime Kulisevsky, Anthony E Lang, Andrew Lees, Sue Leurgans, Peter A LeWitt, David Nyenhuis, C Warren Olanow, Olivier Rascol, Anette Schrag, Jeanne A Teresi, Jacobus J van Hilten, Nancy LaPelle. Mov Disord 2008
Times Cited: 3018







List of co-cited articles
322 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
31

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
25

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
Claire L Tomlinson, Rebecca Stowe, Smitaa Patel, Caroline Rick, Richard Gray, Carl E Clarke. Mov Disord 2010
18

Parkinsonism: onset, progression and mortality.
M M Hoehn, M D Yahr. Neurology 1967
18


Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
12

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.
Irene Litvan, Jennifer G Goldman, Alexander I Tröster, Ben A Schmand, Daniel Weintraub, Ronald C Petersen, Brit Mollenhauer, Charles H Adler, Karen Marder, Caroline H Williams-Gray,[...]. Mov Disord 2012
9

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.
Ian G McKeith, Bradley F Boeve, Dennis W Dickson, Glenda Halliday, John-Paul Taylor, Daniel Weintraub, Dag Aarsland, James Galvin, Johannes Attems, Clive G Ballard,[...]. Neurology 2017
7


Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Christopher G Goetz, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T Stebbins, Carl Counsell, Nir Giladi, Robert G Holloway, Charity G Moore, Gregor K Wenning,[...]. Mov Disord 2004
7


Parkinson's disease: clinical features and diagnosis.
J Jankovic. J Neurol Neurosurg Psychiatry 2008
6

The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.
Kallol Ray Chaudhuri, Pablo Martinez-Martin, Richard G Brown, Kapil Sethi, Fabrizio Stocchi, Per Odin, William Ondo, Kazuo Abe, Graeme Macphee, Doug Macmahon,[...]. Mov Disord 2007
615
6

An inventory for measuring depression.
A T BECK, C H WARD, M MENDELSON, J MOCK, J ERBAUGH. Arch Gen Psychiatry 1961
6

The hospital anxiety and depression scale.
A S Zigmond, R P Snaith. Acta Psychiatr Scand 1983
6

Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks.
Susan Whitfield-Gabrieli, Alfonso Nieto-Castanon. Brain Connect 2012
6

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
5

Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.
Eva Pirogovsky, Dawn M Schiehser, Kristalyn M Obtera, Mathes M Burke, Stephanie L Lessig, David D Song, Irene Litvan, J Vincent Filoteo. Neuropsychology 2014
58
8

The assessment of anxiety states by rating.
M HAMILTON. Br J Med Psychol 1959
5

Construction of freezing of gait questionnaire for patients with Parkinsonism.
Giladi, Shabtai, Simon, Biran, Tal, Korczyn. Parkinsonism Relat Disord 2000
495
5

Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Murat Emre, Dag Aarsland, Richard Brown, David J Burn, Charles Duyckaerts, Yoshikino Mizuno, Gerald Anthony Broe, Jeffrey Cummings, Dennis W Dickson, Serge Gauthier,[...]. Mov Disord 2007
5

Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson's Disease.
Blake J Lawrence, Natalie Gasson, Andrea M Loftus. Sci Rep 2016
32
12

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.
J C Dalrymple-Alford, M R MacAskill, C T Nakas, L Livingston, C Graham, G P Crucian, T R Melzer, J Kirwan, R Keenan, S Wells,[...]. Neurology 2010
508
4

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Antoine Regnault, Babak Boroojerdi, Juliette Meunier, Massimo Bani, Thomas Morel, Stefan Cano. J Neurol 2019
48
8

Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.
Giovanni Rizzo, Massimiliano Copetti, Simona Arcuti, Davide Martino, Andrea Fontana, Giancarlo Logroscino. Neurology 2016
307
4




A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia.
R A Hauser, J Friedlander, T A Zesiewicz, C H Adler, L C Seeberger, C F O'Brien, E S Molho, S A Factor. Clin Neuropharmacol 2000
197
4

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.
Ronald B Postuma, Dag Aarsland, Paolo Barone, David J Burn, Christopher H Hawkes, Wolfgang Oertel, Tjalf Ziemssen. Mov Disord 2012
337
4

International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.
Kallol Ray Chaudhuri, Pablo Martinez-Martin, Anthony H V Schapira, Fabrizio Stocchi, Kapil Sethi, Per Odin, Richard G Brown, William Koller, Paolo Barone, Graeme MacPhee,[...]. Mov Disord 2006
658
4

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
4

Second consensus statement on the diagnosis of multiple system atrophy.
S Gilman, G K Wenning, P A Low, D J Brooks, C J Mathias, J Q Trojanowski, N W Wood, C Colosimo, A Dürr, C J Fowler,[...]. Neurology 2008
4

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
4

Diagnosis and Treatment of Parkinson Disease: A Review.
Melissa J Armstrong, Michael S Okun. JAMA 2020
521
4

Meta-Analysis of Gut Dysbiosis in Parkinson's Disease.
Hiroshi Nishiwaki, Mikako Ito, Tomohiro Ishida, Tomonari Hamaguchi, Tetsuya Maeda, Kenichi Kashihara, Yoshio Tsuboi, Jun Ueyama, Teppei Shimamura, Hiroshi Mori,[...]. Mov Disord 2020
96
4


Quality of life and burden in caregivers for patients with Parkinson's disease: concepts, assessment and related factors.
Pablo Martinez-Martin, Carmen Rodriguez-Blazquez, Maria João Forjaz. Expert Rev Pharmacoecon Outcomes Res 2012
75
4

Prevalence of Parkinson's disease across North America.
C Marras, J C Beck, J H Bower, E Roberts, B Ritz, G W Ross, R D Abbott, R Savica, S K Van Den Eeden, A W Willis,[...]. NPJ Parkinsons Dis 2018
309
3

Physical inactivity in Parkinson's disease.
Marlies van Nimwegen, Arlène D Speelman, Esther J M Hofman-van Rossum, Sebastiaan Overeem, Dorly J H Deeg, George F Borm, Marleen H L van der Horst, Bastiaan R Bloem, Marten Munneke. J Neurol 2011
178
3

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.
Irene Litvan, Dag Aarsland, Charles H Adler, Jennifer G Goldman, Jaime Kulisevsky, Brit Mollenhauer, Maria C Rodriguez-Oroz, Alexander I Tröster, Daniel Weintraub. Mov Disord 2011
493
3

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
J C Klein, C Eggers, E Kalbe, S Weisenbach, C Hohmann, S Vollmar, S Baudrexel, N J Diederich, W D Heiss, R Hilker. Neurology 2010
214
3

The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort.
Konrad Szewczyk-Krolikowski, Paul Tomlinson, Kannan Nithi, Richard Wade-Martins, Kevin Talbot, Yoav Ben-Shlomo, Michele T M Hu. Parkinsonism Relat Disord 2014
165
3

Measurement of functional activities in older adults in the community.
R I Pfeffer, T T Kurosaki, C H Harrah, J M Chance, S Filos. J Gerontol 1982
3

Lewy body dementias.
Zuzana Walker, Katherine L Possin, Bradley F Boeve, Dag Aarsland. Lancet 2015
268
3


The clinically important difference on the unified Parkinson's disease rating scale.
Lisa M Shulman, Ann L Gruber-Baldini, Karen E Anderson, Paul S Fishman, Stephen G Reich, William J Weiner. Arch Neurol 2010
327
3

Voice changes in Parkinson's disease: What are they telling us?
Andrew Ma, Kenneth K Lau, Dominic Thyagarajan. J Clin Neurosci 2020
15
20

Neural correlates underlying micrographia in Parkinson's disease.
Tao Wu, Jiarong Zhang, Mark Hallett, Tao Feng, Yanan Hou, Piu Chan. Brain 2016
47
6

Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers.
Alice Nieuwboer, Lynn Rochester, Talia Herman, Wim Vandenberghe, George Ehab Emil, Tom Thomaes, Nir Giladi. Gait Posture 2009
338
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.